William Pao's most recent trade in Immunocore Holdings plc - ADR was a trade of 26,198 Share Option (Right to Buy) done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunocore Holdings plc - ADR | William Pao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 26,198 | 26,198 | - | - | Share Option (Right to Buy) | |
| Immunocore Holdings plc - ADR | William Pao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 24,443 | 24,443 | - | - | Share Option (Right to Buy) | |
| Pfizer | William Pao | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.80 per share. | 31 Mar 2023 | 22,095 | 97,765 (0%) | 0% | 40.8 | 901,476 | Common Stock |
| Pfizer | William Pao | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 80,360 | 80,360 | - | - | Stock Appreciation Rights | |
| Pfizer | William Pao | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 69,938 | 69,938 | - | - | Stock Appreciation Rights | |
| Pfizer | William Pao | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 115,897 | 115,897 (0%) | 0% | 0 | Common Stock |